Oxford Science Enterprises

#portfolionews Congratulations to Walter Goodwin and the Fractile team for the completion of a new investment round, raising $15m to develop their revolutionary AI chip technology! The investment was co-led by OSE, Kindred Capital VC, and the NATO Innovation Fund (NIF).   OSE’s Sam Harman said: “Fractile has developed a radically innovative approach to solve one of the AI sector’s biggest challenges. We’re delighted to be supporting them and look forward to seeing the company accelerate its development while contributing to the UK’s growing reputation as an amazing place to build an AI company.”   Check out Walter’s interview with Fortune on the announcement here: https://lnkd.in/esdzV-rr   #AI #Innovation #TechFunding #FutureOfAI

✍ We're proud to support the launch of Oxford-Cambridge Supercluster Board's policy recommendations, sent to the UK government this week, on how we can supercharge economic growth via the UK's innovation sector. Our CEO Edward Bussey signed the letter sent to government, alongside 45 leaders from the country's leading innovation businesses, advocating for the adoption of six critical policies to support the UK's position as a global leader in science and technology. Financial Times article on the initiative: https://lnkd.in/dq5VujkW Full details on the recommendations below ⤵

📣 Calling the next generation of healthcare innovators and VCs to participate in Oxford Venture Capital Network's first #HealthTech VC Programme! We're proud to collaborate with OXVC, alongside EQT Group, in the 3 month program kicking off in November 2024. OSE's Heather Roxborough and Tatiana Lobanov-Rostovsky will be on hand to provide mentorship and support to the participants throughout. Full details below: About the Programme: OXVC's Health Tech VC Programme is a 3-month training program designed to foster the next generation of healthcare innovators and venture capitalists. This program focuses on AI in diagnostics and therapeutics, among other emerging areas in health tech, providing you with the tools to transform research into real-world applications. Who Should Apply? We are looking for multidisciplinary teams that blend technological innovation with practical application and commercialization. If you are passionate about health tech and want to be part of a community that will shape the future of healthcare, please apply to join. A healthcare, STEM or business background is required, we are looking at DPhils, (E)MBAs and post-grads, but if you have a unique case to make for your application, we're open to hearing it.   How to Apply: The first round of applications is open now and closes on August 31st ⤵ 👉  https://lnkd.in/gyyC3G-4 👈

Congratulations to Sumi Biswas and the team at SpyBiotech on the completion of enrollment in their Phase I clinical trial for a vaccine targeting human cytomegalovirus (HCMV). HCMV is a common virus that can cause serious problems in newborns and individuals with weakened immune systems. There is no approved vaccine for this virus yet, and this achievement brings us one step closer to addressing this important health challenge.

#PortfolioNews - Congratulations to Caroline Cake and the team at Neu Health on the outcomes of their first NHS evaluation! This is a significant step towards enhancing Parkinson’s care and demonstrates the real-life impact of Neu Health’s pioneering technology. Read more about the announcement below ⤵

#PortfolioNews - Congratulations to Pete Armstrong and the team at Mixergy Ltd on their partnership with Daikin UK, a first for the industry! The combination of Daikin’s Altherma heat pump with Mixergy’s smart hot-water cylinder offers unparalleled benefits to social housing providers and new build developers, allowing them to deliver on their promise to provide better homes for homeowners and tenants while significantly reducing carbon emissions. Read more about the announcement ⤵ 

#PortfolioNews – Exciting news from the Oxford Semantic Technologies (OST) team who announced today that the company has been acquired by Samsung Electronics. Samsung will use OST’s RDFox® technology across a wide range of products, including mobile devices, televisions and home appliances. We’re extremely proud to have supported OST since it was spun out of the Oxford University Computer Science Department in 2017. It is a great example of how developments in deep tech can be deployed in consumer technology, with RDFox® set to be integrated into appliances in homes around the world. Full announcement here ⤵ https://lnkd.in/e9if_Pfn

Welcome to Dr Mark Bodmer as CEO of Nucleome Therapeutics. https://lnkd.in/ebXAVgJF.  Commenting, Mark said: “Nucleome has built a revolutionary technology platform which moves the field of genetics in medicine from its 1-Dimensional linear code to the interactions within its 3-Dimensional structure. This allows us to determine the regulatory wiring of gene function in health and disease in unprecedented detail. Variants in non-coding regions of the genome can be mapped to the genes they control, which are often far away in 1-D but are next-door neighbours in 3-D. Nucleome’s uniquely powerful technology fills a critical gap in the application of genetics to drug discovery and healthcare. The vast majority of genome sequence variants lie outside of protein-coding regions. Yet they play a critical role in shaping biological function and disease. Nucleome’s capability to bridge these sequence variants to biology brings genomics into an entirely new era of the application of genetics to drug target discovery and precision medicine. It is a privilege to be given the opportunity to lead this ground-breaking company into its next phase of growth.”    #CEO #hiring #biotech #genomics

Huge step forward in the space of quantum computing from one of our portfolio companies as Oxford Ionics breaks records with the highest performing quantum chip in the world.   The advancements they have made in controlling high performance qubits will allow them to build powerful and commercially-useful quantum computers. This represents a significant milestone towards bringing scalable, high performance quantum chips to market. We're very proud to back companies developing pioneering technologies where the UK has a genuine first-mover advantage!   Read more about the news story here ⤵ https://lnkd.in/dfkxWrBH

#PortfolioNews - Congratulations to Virginia Corless and the team at Moa Technology on their partnership with Nufarm, a global agricultural innovator based in Melbourne, Australia. Moa’s breakthrough innovation platform has discovered several promising new classes of herbicide and Moa and Nufarm will work together to commercialise their groundbreaking weed management solution and take it to market. This partnership is an important milestone that seeks to address the challenge of resistant weeds and respond to the demand for new, safe and effective herbicides. Read more about the announcement ⤵  https://lnkd.in/eD7_AQbx